Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-312024-01-01false82990 - Other business support service activities not elsewhere classified22truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 04747824 2024-01-01 2024-12-31 04747824 2023-01-01 2023-12-31 04747824 2024-12-31 04747824 2023-12-31 04747824 c:Director1 2024-01-01 2024-12-31 04747824 d:Buildings 2024-12-31 04747824 d:Buildings 2023-12-31 04747824 d:CurrentFinancialInstruments 2024-12-31 04747824 d:CurrentFinancialInstruments 2023-12-31 04747824 d:Non-currentFinancialInstruments 2024-12-31 04747824 d:Non-currentFinancialInstruments 2023-12-31 04747824 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 04747824 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 04747824 d:Non-currentFinancialInstruments d:AfterOneYear 2024-12-31 04747824 d:Non-currentFinancialInstruments d:AfterOneYear 2023-12-31 04747824 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2024-12-31 04747824 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2023-12-31 04747824 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2024-12-31 04747824 d:Non-currentFinancialInstruments d:BetweenTwoFiveYears 2023-12-31 04747824 d:ShareCapital 2024-12-31 04747824 d:ShareCapital 2023-12-31 04747824 d:RetainedEarningsAccumulatedLosses 2024-12-31 04747824 d:RetainedEarningsAccumulatedLosses 2023-12-31 04747824 c:OrdinaryShareClass1 2024-01-01 2024-12-31 04747824 c:OrdinaryShareClass1 2024-12-31 04747824 c:OrdinaryShareClass1 2023-12-31 04747824 c:FRS102 2024-01-01 2024-12-31 04747824 c:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 04747824 c:FullAccounts 2024-01-01 2024-12-31 04747824 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 04747824 e:PoundSterling 2024-01-01 2024-12-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 04747824










HORIZON BLOODSTOCK LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2024



 
HORIZON BLOODSTOCK LIMITED
REGISTERED NUMBER: 04747824

BALANCE SHEET
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Tangible assets
 4 
184,962
184,962

  
184,962
184,962

Current assets
  

Biological assets
 5 
68,200
118,922

Debtors: amounts falling due within one year
 6 
30,828
5,040

Cash at bank and in hand
 7 
68
2,564

  
99,096
126,526

  

Creditors: amounts falling due within one year
 8 
(3,912,849)
(3,846,052)

Net current liabilities
  
 
 
(3,813,753)
 
 
(3,719,526)

Total assets less current liabilities
  
(3,628,791)
(3,534,564)

Creditors: amounts falling due after more than one year
 9 
(28,598)
(34,758)

  

Net liabilities
  
(3,657,389)
(3,569,322)


Capital and reserves
  

Called up share capital 
 11 
1,000
1,000

Profit and loss account
  
(3,658,389)
(3,570,322)

  
(3,657,389)
(3,569,322)


Page 1

 
HORIZON BLOODSTOCK LIMITED
REGISTERED NUMBER: 04747824

BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




M J Caddy
Director

Date: 11 December 2025

The notes on pages 3 to 8 form part of these financial statements.

Page 2

 
HORIZON BLOODSTOCK LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

Horizon Bloodstock Limited is a private company limited by share capital and incorporated in England and Wales.

The address of its registered office and principal place of business is Ox Drove Farm, Burghclere, Newbury, Berkshire, RG20 9DU.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the requirements and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

 
2.2

Going concern

The financial statements have been produced on the going concern basis as the directors consider that appropriate funds will continue to be available to enable the company to meet its third party liabilities as they fall due. This is based on the company continuing to receive the financial support of the directors. At the balance sheet date a director was owed £3,871,370 (2023: £3,871,087) by the company.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

Page 3

 
HORIZON BLOODSTOCK LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

  
2.4

Biological assets

Bloodstock is recognised as a biological asset and is accounted for under the cost model in accordance with FRS 102.  

The cost of horses purchased is the purchase price plus purchase costs.

The cost of foals born is the cost of the stallion nomination fee plus keep cost.

The cost of youngstock is increased by costs of keep each year until they are sold or transferred into training.  

At the balance sheet date bloodstock is assessed on an individual animal basis for impairment.  If stock is impaired, the carrying amount is reduced to its estimated market value less costs to sell.  The impairment loss is recognised immediately in profit or loss.  This is considered to be more appropriate than applying a systematic depreciation charge. 

  
2.5

Tangible fixed assets

Tangible fixed assets comprise freehold land held at cost and not depreciated.

 
2.6

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.7

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.9

Financial instruments

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Page 4

 
HORIZON BLOODSTOCK LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2023 - 2).


4.


Tangible fixed assets


Freehold property

£



Cost or valuation


At 1 January 2024
184,962



At 31 December 2024

184,962






Net book value



At 31 December 2024
184,962



At 31 December 2023
184,962


5.


Biological assets

2024
2023
£
£

Bloodstock - biological assets
68,200
118,922

68,200
118,922



6.


Debtors

2024
2023
£
£


Other debtors
1,707
5,040

Prepayments and accrued income
29,121
-

30,828
5,040


Page 5

 
HORIZON BLOODSTOCK LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

7.


Cash and cash equivalents

2024
2023
£
£

Cash at bank and in hand
68
2,564

Less: bank overdrafts
(7)
-

61
2,564



8.


Creditors: Amounts falling due within one year

2024
2023
£
£

Bank overdrafts
7
-

Trade creditors
31,079
25,228

Accruals and deferred income
3,529
3,873

Bounce back loan
6,864
6,864

Other creditors
3,871,370
3,810,087

3,912,849
3,846,052



9.


Creditors: Amounts falling due after more than one year

2024
2023
£
£

Bounce back loan
28,598
34,758

28,598
34,758


Page 6

 
HORIZON BLOODSTOCK LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

10.


Loans


Analysis of the maturity of loans is given below:


2024
2023
£
£

Amounts falling due within one year

Bounce back loan
6,864
6,864

Amounts falling due 1-2 years

Bounce back loan
6,864
6,864

Amounts falling due 2-5 years

Bounce back loan
21,734
27,894


35,462
41,622


Page 7

 
HORIZON BLOODSTOCK LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

11.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



1,000 (2023 - 1,000) Ordinary shares of £1 each
1,000
1,000



12.


Related party transactions

At the balance sheet date, M J Caddy, a director of the company, was owed £3,871,370 (2023: £3,810,087) by the company. This amount is unsecured, does not bear interest and will only be repayable if the company can remain solvent immediately following repayment. 

The company has taken advantage of the disclosure exemption available under FRS 102 Section 33.1A not to disclose transactions entered into between 100% owned group companies.


13.


Controlling party

The company's immediate parent company is H & H Holdings (Newbury) Limited, a company registered in England and Wales. The ultimate controlling party is M J Caddy by virtue of their 100% shareholding in H & H Holdings (Newbury) Limited.


Page 8